Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

KPMG to exit cannabis industry audits, Cronos seeks new firm

Published 04/17/2024, 08:18 PM
Updated 04/17/2024, 08:18 PM

In a recent development, Cronos Group Inc. (NASDAQ:CRON), a key player in the cannabis industry, will be searching for a new independent registered public accounting firm. On Monday, KPMG LLP, the company's current auditor, notified Cronos that it would not seek reappointment for the 2024 annual audit. This decision is part of KPMG's broader move to stop providing audit services to cannabis companies altogether.

The accounting firm's choice to withdraw from auditing cannabis-related businesses is not specific to Cronos Group, as it applies to the entire industry. KPMG has committed to reviewing Cronos' quarterly interim results through the first two quarters of 2024, ensuring some continuity in the short term.

KPMG's relationship with Cronos has been without significant conflict, as there have been no disagreements or reportable events, except for a previously disclosed material weakness in internal controls over financial reporting in 2022. The auditing firm provided an unqualified opinion on Cronos' consolidated financial statements for the fiscal years ending December 31, 2023, and 2022, and on the company's internal controls for 2023.

The company's leadership, including the Board of Directors and the Audit Committee, was not involved in KPMG's decision not to stand for reappointment. Cronos Group plans to initiate the process of appointing a new auditor promptly.

The information for this article is based on a recent SEC filing.

InvestingPro Insights

Amidst the news of Cronos Group Inc. (NASDAQ:CRON) seeking a new auditor, investors may be evaluating the company's financial health and market position. According to InvestingPro data, Cronos holds a market capitalization of $928.89 million, indicating its size and scale within the cannabis industry. Despite challenges, the company's financials reveal certain strengths. Notably, Cronos is currently trading at a low revenue valuation multiple, which could suggest that the company's stock is undervalued relative to its sales.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Moreover, an InvestingPro tip highlights that Cronos has more cash than debt on its balance sheet, which is a reassuring sign of financial stability. This is further supported by the fact that Cronos' liquid assets exceed its short-term obligations, indicating a strong liquidity position that may help the company navigate through the transition of appointing a new auditor and beyond.

Investors looking for additional insights can find a wealth of information on InvestingPro, including detailed financial metrics and expert analysis. For those interested in a deeper dive into Cronos Group's investment potential, InvestingPro offers more tips, such as the company's recent strong return over the last month and three months. There are a total of 10 additional InvestingPro Tips available for Cronos, which can be accessed at: https://www.investing.com/pro/CRON. To enhance your investing strategy, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.